Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple 3H-5-hydroxytryptamine binding sites in rat brain

D L Nelson, N W Pedigo, H I Yamamura

    Journal De Physiologie
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Efficacy of a new schistosomicidal agent 2-[(methylpropyl)amino]-1-octanethiosulfuric acid against an oxamniquine resistant Schistosoma mansoni isolate.

    Memorias do Instituto Oswaldo Cruz·1999
    Same author

    Regulation and function of WASp in platelets by the collagen receptor, glycoprotein VI.

    Blood·1999
    Same author

    Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott-Aldrich syndrome patients carrying 'null' mutations.

    Gene therapy·1999
    Same author

    Alternative splicing in the murine and human FXR1 genes.

    Genomics·1999
    Same author

    The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation.

    Blood·1999
    Same author

    Cue set size effects: sampling activated associates or cross-target interference?

    Memory & cognition·1999

    Spiperone reveals distinct serotonin (5-HT) binding sites in rat brain regions. A new compound, AHR 1709B, selectively targets these serotonin binding sites, paving the way for novel drug development.

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Biochemistry

    Background:

    • Serotonin (5-HT) plays a crucial role in various brain functions.
    • Understanding the heterogeneity of 5-HT binding sites is essential for developing targeted therapeutics.
    • Previous studies suggested multiple 5-HT binding sites, but regional differences were not well-defined.

    Purpose of the Study:

    • To investigate the effects of spiperone on 3H-5-HT binding in rat diencephalon and lower brain stem.
    • To compare these binding characteristics with those in telencephalic structures.
    • To identify compounds that can discriminate between different types of 3H-5-HT binding sites.

    Main Methods:

    • Radioligand binding assays using spiperone and 3H-5-HT.
    • Preparation of membrane fractions from different rat brain regions (diencephalon, lower brain stem, telencephalon).

    Related Experiment Videos

  • Testing the differential affinity of various compounds, including AHR 1709B, for 5-HT binding sites in specific brain areas.

    • Main Results:

    • Spiperone exhibited complex inhibition curves in non-telencephalic areas, suggesting diverse high-affinity 3H-5-HT binding sites.
    • Binding curves in the diencephalon and lower brain stem showed distinct patterns compared to telencephalic regions, with some concentrations of spiperone increasing binding.
    • AHR 1709B demonstrated a 10-fold higher potency in the rat frontal cortex compared to the corpus striatum, indicating selective recognition of binding sites.

    Conclusions:

    • The study confirms the existence of multiple types of 3H-5-HT binding sites in the rat brain.
    • Significant regional differences in 5-HT binding site characteristics have been identified.
    • The discovery of AHR 1709B provides a valuable tool for studying serotoninergic function and developing selective drugs.